Adhera Therapeutics Inc (ATRX)
Adhera Therapeutics, Inc. is a biotechnology company listed on OTC Markets as common stock under the ticker ATRX. The company focuses on the discovery, development, and commercialization of small molecule drug candidates. Its pipeline includes MLR-1019, which is being developed for Parkinson’s disease, and MLR-1023, which is being developed for Type 1 diabetes. The company was previously known as Marina Biotech, Inc. and adopted its current name in October 2018. Adhera Therapeutics is based in Baton Rouge, Louisiana.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-ATRX
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
1.162 K
|
